Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

Clinical trial NCT06971380 · RECRUITING

Trial details

NCT number: NCT06971380
Sponsor: Polina Stepensky
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma, Refractory to Standard Treatment Multiple Myeloma, Relapsed Light Chain Amyloidosis

Start date: 2025-03-01
Primary completion: 2028-05-15
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.